Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Davis

Showing results (41-50 of 229) with videos related to

Pageof 23
Sort By:
BJU International|October 25, 2019
BJUI Compass and open accessProkar Dasgupta, John W Davis
Journal of Endourology|December 24, 2011
Robotic surgery training with commercially available simulation systems in 2011: a current review and practice pattern survey from the society of urologic robotic surgeonsCostas D Lallas, John W Davis,
BMJ Open|June 16, 2021
Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patientsJohn W Davis, Susan C Weller
JAMA Network Open|April 7, 2026
Expanded Lipid Biomarkers and Estimating Risk Beyond PREVENTJohn W Davis, JoAnn E Manson
Journal of the American College of Cardiology|April 28, 2022
Exercise and Mortality in Heart Disease Cohorts: Meta-Analysis to Augment Available EvidenceChristie M Ballantyne, John W Davis
Clinical Prostate Cancer|April 10, 2004
An evaluation of bicalutamide in the treatment of prostate cancerPaul F Schellhammer, John W Davis
Chemosphere|September 24, 2002
An examination of the physical properties, fate, ecotoxicity and potential environmental risks for a series of propylene glycol ethersCharles A Staples, John W Davis
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Genomic-based biomarkers of drug-induced nephrotoxicityJohn W Davis, Jeffrey A Kramer
Current Urology Reports|November 10, 2012
Lymphadenectomy with robotic cystectomyJohn W Davis, Ashish M Kamat
JAMA Network Open|September 8, 2025
Glucagon-Like Peptide-1 Receptor Agonists for Preventing Cardiorenal ComplicationsJohn W Davis, Karen E Joynt Maddox
Pageof 23

Showing results (41-50 of 229) with videos related to

Sort By:
Pageof 23
BJU International|October 25, 2019
BJUI Compass and open accessProkar Dasgupta, John W Davis
Journal of Endourology|December 24, 2011
Robotic surgery training with commercially available simulation systems in 2011: a current review and practice pattern survey from the society of urologic robotic surgeonsCostas D Lallas, John W Davis,
BMJ Open|June 16, 2021
Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patientsJohn W Davis, Susan C Weller
JAMA Network Open|April 7, 2026
Expanded Lipid Biomarkers and Estimating Risk Beyond PREVENTJohn W Davis, JoAnn E Manson
Journal of the American College of Cardiology|April 28, 2022
Exercise and Mortality in Heart Disease Cohorts: Meta-Analysis to Augment Available EvidenceChristie M Ballantyne, John W Davis
Clinical Prostate Cancer|April 10, 2004
An evaluation of bicalutamide in the treatment of prostate cancerPaul F Schellhammer, John W Davis
Chemosphere|September 24, 2002
An examination of the physical properties, fate, ecotoxicity and potential environmental risks for a series of propylene glycol ethersCharles A Staples, John W Davis
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Genomic-based biomarkers of drug-induced nephrotoxicityJohn W Davis, Jeffrey A Kramer
Current Urology Reports|November 10, 2012
Lymphadenectomy with robotic cystectomyJohn W Davis, Ashish M Kamat
JAMA Network Open|September 8, 2025
Glucagon-Like Peptide-1 Receptor Agonists for Preventing Cardiorenal ComplicationsJohn W Davis, Karen E Joynt Maddox
Pageof 23